quinacrine has been researched along with sr141716 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Awumey, EM; Bukoski, RD; Diz, DI; Hill, SK | 1 |
3 other study(ies) available for quinacrine and sr141716
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Cytochrome P-450 metabolites of 2-arachidonoylglycerol play a role in Ca2+-induced relaxation of rat mesenteric arteries.
Topics: 8,11,14-Eicosatrienoic Acid; Acetylcholine; Animals; Arachidonic Acids; Calcium; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; Glycerides; Lipoprotein Lipase; Male; Mesenteric Arteries; Miconazole; Peptides; Phenylephrine; Phospholipase A2 Inhibitors; Phospholipases A2; Piperidines; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Pyrazoles; Quinacrine; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, Calcium-Sensing; Rimonabant; Signal Transduction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2008 |